Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19

• Florian Tran,
• Danielle M.M. Harris,
• Alena Scharmacher,
• Hanna Graßhoff,
• Kristina Sterner,
• Susanne Schinke,
• Nadja Käding,
• Jens Y. Humrich,
• Otávio Cabral-Marques,
• Joana P. Bernardes,
• Neha Mishra,
• Thomas Bahmer,
• Jeanette Franzenburg,
• Bimba F. Hoyer,
• Andreas Glück,
• Martina Guggeis,
• Alexander Ossysek,
• Andre Küller,
• Derk Frank,
• Christoph Lange,
• Jan Rupp,
• Jan Heyckendorf,
• Karoline I. Gaede,
• Howard Amital,
• Philip Rosenstiel,
• Yehuda Shoenfeld,
• Gilad Halpert,
• Avi Z. Rosenberg,
• Kai Schulze-Forster,
• Harald Heidecke,
• Gabriela Riemekasten,
• Stefan Schreiber

Affiliations

Florian Tran

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Danielle M.M. Harris

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Alena Scharmacher

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Hanna Graßhoff

Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany

Kristina Sterner

Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany

Susanne Schinke

Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany

Nadja Käding

Department of Infectious Diseases and Microbiology, University Medical Center Schleswig-Holstein, Lübeck, Germany

Jens Y. Humrich

Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany

Otávio Cabral-Marques

Department of Immunology, Instituto de Ciencias Biomedicas, Universidade de São Paulo, São Paulo, SP, Brazil

Joana P. Bernardes

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Neha Mishra

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Thomas Bahmer

Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany

Jeanette Franzenburg

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Bimba F. Hoyer

Section for Rheumatology, Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany

Andreas Glück

Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany

Martina Guggeis

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Alexander Ossysek

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Andre Küller

Department of Internal Medicine III, University Medical Center Schleswig-Holstein, Kiel, Germany

Derk Frank

Department of Internal Medicine III, University Medical Center Schleswig-Holstein, Kiel, Germany

Christoph Lange

Research Center Borstel, Borstel, Germany

Jan Rupp

Department of Infectious Diseases and Microbiology, University Medical Center Schleswig-Holstein, Lübeck, Germany

Jan Heyckendorf

Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany

Karoline I. Gaede

Research Center Borstel, Borstel, Germany

Howard Amital

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel

Philip Rosenstiel

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Yehuda Shoenfeld

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel

Gilad Halpert

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat-Gan, Israel

Avi Z. Rosenberg

Department of Pathology, Johns Hopkins University, Baltimore, MD, USA

Kai Schulze-Forster

CellTrend GmbH, Luckenwalde, Germany

Harald Heidecke

CellTrend GmbH, Luckenwalde, Germany

Gabriela Riemekasten

Institute for Human Nutrition and Food Science, University Medical Center Schleswig-Holstein, Kiel, Germany

Stefan Schreiber

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany